BMAL1 and metabolic syndrome: In individuals with metabolic syndrome, dysregulated BMAL1 function in adipose tissue leads to imbalances in metabolic processes (such as alterations in NADPH levels, mitochondrial electron transport, diurnal activation of UCP1, and inhibition of NF-κB, ultimately disrupting normal energy balance) [57,58,59].